Phaseline

Targets › FLUB

FLUB: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 3; Infectious disease; next expected readout Mar 2027.

Open in Phaseline: the race on FLUB, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Unity Health TorontoBaloxavir
CAP-dependent endonuclease inhibitor
FLUA, FLUBPhase 3Influenza AMar 2027

Conditions

Influenza A (1)

Modalities

small molecule (1)

Companies

Unity Health Toronto (1)

Related targets

FLUA (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.